Forward Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, May 14, 2024 /PRNewswire/ — Mason Capital Management LLC, a Delaware limited liability company (“Mason Capital”), announced today that it has commenced a tender offer (the “Tender Offer”) for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the “Company”) for a purchase price of $437.00 per ADS or […]

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Forward Pharma A/S (“Forward” or the “Company”) today announced that its Board of Directors has approved a termination of the Deposit Agreement, dated October 14, 2014, among Forward Pharma A/S (Forward Pharma), the Depositary Bank of New York Mellon, and Owners and Holders of ADRs. As a result, the existing ADR facility will be terminated effective at 5:00 PM (Eastern Time) on February 5, 2024. Kindly see additional information at the websi

Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023 Dr. Daniel G. Billen appointed Chair of the Board of Directors ...

Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023Dr. Daniel G. Billen appointed Chair of the Board of DirectorsEDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors has appointed...

RESULTS OF 2023 ANNUAL MEETING OF SHAREHOLDERS The annual general meeting of the shareholders of Forward Pharma A/S was held on June 8, 2023 at the Company's... | June 12, 2023